Vitamin D deficiency and graft-versus-host disease in hematopoietic stem cell transplant population

Mora, 2008, Vitamin effects on the immune system: vitamins A and D take centre stage, Immunology, 8, 685 Rosenberg, 2007, Challenges and opportunities in the translation of the science of vitamins, Am J Clin Nutr, 85, 325S, 10.1093/ajcn/85.1.325S Feldman, 2008, Vitamin D: biology, action, and clinical implications, 317 Adams, 2010, Update in vitamin D, J Clin Endocrinol Metab, 95, 471, 10.1210/jc.2009-1773 Llesuy, 1995, Effect of vitamins A and E on ischemia reperfusion damage in rabbit heart, Mol Cell Biochem, 145, 45, 10.1007/BF00925712 Holick, 2007, Vitamin D deficiency, N Engl J Med, 357, 266, 10.1056/NEJMra070553 Bikle, 2009, Nonclassic actions of vitamin D, J Clin Endocrinol Metab, 94, 26, 10.1210/jc.2008-1454 2005 van Etten, 2005, Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts, J Steroid Biochem Mol Biol, 97, 93, 10.1016/j.jsbmb.2005.06.002 Verstuyf, 2010, Vitamin D: a pleiotropic hormone, Kidney Int, 78, 140, 10.1038/ki.2010.17 Gombart, 2006, Vitamin D compounds: activity against microbes and cancer, Anticancer Res, 26, 2531 Bener, 2011, Vitamin D deficiency as a strong predictor of asthma in children, Int Arch Allergy Appl Immunol, 157, 168, 10.1159/000323941 Baeke, 2010, Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system, J Steroid Biochem Mol Biol, 121, 221, 10.1016/j.jsbmb.2010.03.037 Robien, 2011, Vitamin D status among long-term survivors of hematopoietic stem cell transplantation, Bone Marrow Transplant, 46, 1472, 10.1038/bmt.2010.326 Akeno, 1997, Mouse vitamin D-24-hydroxylase: molecular cloning, tissue distribution, and transcriptional regulation by 1α, 25-dihydroxyvitamin D3, Endocrinology, 138, 2233, 10.1210/endo.138.6.5170 Rigby, 1984, Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol), J Clin Invest, 74, 1451, 10.1172/JCI111557 Bhalla, 1986, Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production, Cell Immunol, 98, 311, 10.1016/0008-8749(86)90291-1 Blomhoff, 2006, Overview of retinoid metabolism and function, J Neurobiol, 66, 606, 10.1002/neu.20242 Chen, 2007, Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation, J Immunol, 179, 1634, 10.4049/jimmunol.179.3.1634 Lemire, 1984, 1α,25-Dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells, J Clin Invest, 74, 657, 10.1172/JCI111465 Moise, 2007, Delivery of retinoid-based therapies to target tissues, Biochemistry, 46, 4449, 10.1021/bi7003069 Fritsche, 2003, Regulation of 25-hydroxyvitamin D3–1α-hydroxylase and production of 1α, 25-dihydroxyvitamin D3 by human dendritic cells, Blood, 102, 3314, 10.1182/blood-2002-11-3521 Penna, 2000, 1 Alpha, 25-hydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation, J Immunol, 164, 2405, 10.4049/jimmunol.164.5.2405 Ohta, 1985, 1α,25-Dihydroxyvitamin D3 (calcitriol) stimulates proliferation of human circulating monocytes in vitro, FEBS Lett, 185, 9, 10.1016/0014-5793(85)80730-4 de Lera, 2007, Design of selective nuclear receptor modulators: RAR and RXR as a case study, Nat Rev Drug Discov, 6, 811, 10.1038/nrd2398 Lampen, 2000, Metabolism of vitamin A and its active metabolite all-trans-retinoic acid in small intestinal enterocytes, J Pharmacol Exp Ther, 295, 979 Muller, 1995, Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus, Clin Rheumatol, 14, 397, 10.1007/BF02207671 Iwata, 2004, Retinoic acid imprints gut-homing specificity on T cells, Immunity, 21, 527, 10.1016/j.immuni.2004.08.011 Cutolo, 2007, Vitamin D in rheumatoid arthritis, Autoimmun Rev, 7, 59, 10.1016/j.autrev.2007.07.001 Coombs, 2007, A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β- and retinoic acid-dependent mechanism, J Exp Med, 204, 1757, 10.1084/jem.20070590 Mathieu, 2005, Vitamin D and diabetes, Diabetologia, 48, 1247, 10.1007/s00125-005-1802-7 Germain, 2006, International union of pharmacology: LXIII. Retinoid X receptors, Pharmacol Rev, 58, 760, 10.1124/pr.58.4.7 Bastie, 2004, 1α,25-Dihydroxyvitamin D3 transrepresses retinoic acid transcriptional activity via vitamin D receptor in myeloid cells, Mol Endocrinol, 18, 2685, 10.1210/me.2003-0412 Schug, 2007, Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors, Cell, 129, 723, 10.1016/j.cell.2007.02.050 Garland, 2007, Vitamin D and prevention of breast cancer: pooled analysis, J Steroid Biochem Mol Biol, 103, 708, 10.1016/j.jsbmb.2006.12.007 Allavena, 2008, Pathways connecting inflammation and cancer, Curr Opin Genet Dev, 18, 3, 10.1016/j.gde.2008.01.003 Hawk, 2002, COX-2 in cancer—a player that’s defining the rules, J Natl Cancer Inst, 94, 545, 10.1093/jnci/94.8.545 Ahn, 2008, Serum vitamin D concentration and prostate cancer risk: a nested case-control study, J Natl Cancer Inst, 2008, 796, 10.1093/jnci/djn152 KrishnanAV, 2007, Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity, J Bone Miner Res, 22, V74, 10.1359/jbmr.07s213 Holick, 1996, Vitamin D and bone health, J Nutr, 126, 1159S, 10.1093/jn/126.suppl_4.1159S Kananen, 2005, Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin-D, and sex hormone replacement with or without pamidronate, J Clin Enodcrinol Metab, 90, 3877, 10.1210/jc.2004-2161 Kreutz, 2004, Variations in 1 alpha,25-dihyroxyvitamin D3 and 25-hydroxyvitamin D3 serum levels during allogenic bone marrow transplantation, Bone Marrow Transplant, 33, 871, 10.1038/sj.bmt.1704448 Bechard, 2015, Bone loss and vitamin-D deficiency until undergoing hematopoietic cell transplantation, Pediatr Blood Cancer, 62, 687, 10.1002/pbc.25370 Campos, 2014, Bone mineral density, vitamin D, and nutritional status of children submitted to hematopoietic stem cell transplantation, Nutrition, 30, 654, 10.1016/j.nut.2013.10.014 Rizzo, 2006, Recommended screening and preventive practices for long-term survivors after hematopoietic stem cell transplantation: joint recommendations for the European Group for Blood and Marrow Transplant Research, Biol Blood Marrow Transplant, 12, 138, 10.1016/j.bbmt.2005.09.012 Fink, 2011, Vitamin D deficiency is a cofactor of chemotherapy-induced mucocutaneous toxicity and dysgeusia, J Clin Oncol, 29, e81, 10.1200/JCO.2010.31.5317 Kitchen, 2012, The relationship between vitamin-D and chemotherapy-induced toxicity—a pilot study, Br J Cancer, 107, 158, 10.1038/bjc.2012.194 Socie, 2014, Current issues in chronic graft-versus-host disease, Blood, 124, 374, 10.1182/blood-2014-01-514752 Arora, 2016, Late acute and chronic graft-versus-host disease after allogeneic hematopoetic cell transplantation, Biol Bone Marrow Transplant, 22, 449, 10.1016/j.bbmt.2015.10.018 Ferrara, 2009, Graft–versus–host disease, Lancet, 373, 1550, 10.1016/S0140-6736(09)60237-3 Hill, 2000, The primacy of the gastrointestinal tract as a target organ of acute graft–versus–host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation, Blood, 95, 2754, 10.1182/blood.V95.9.2754.009k25_2754_2759 Hossain, 2011, Flagellin, a TLR5 agonist, reduces graft–versus–host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity, J Immunol, 187, 5130, 10.4049/jimmunol.1101334 Penack, 2010, Graft–versus–host disease: regulation by microbe-associated molecules and innate immune receptors, Blood, 115, 1865, 10.1182/blood-2009-09-242784 Matte, 2004, Donor APCs are required for maximal GVHD but not for GVL, Nat Med, 10, 987, 10.1038/nm1089 Shlomchik, 1999, Prevention of graft versus host disease by inactivation of host antigen-presenting cells, Science, 285, 412, 10.1126/science.285.5426.412 Schultz, 1995, Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft–versus–host disease, Bone Marrow Transplant, 16, 289 Knoechel, 2005, The link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance, J Immunol, 175, 21, 10.4049/jimmunol.175.1.21 Kapur, 2008, B-cell involvement in chronic graft-versus-host disease, Haematologica, 93, 1702, 10.3324/haematol.13311 Shimabukuro-Vornhagen, 2009, The role of B cells in the pathogenesis of graft-versus-host disease, Blood, 114, 4919, 10.1182/blood-2008-10-161638 Miklos, 2005, Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission, Blood, 105, 2973, 10.1182/blood-2004-09-3660 Miklos, 2004, Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors, Blood, 103, 353, 10.1182/blood-2003-03-0984 Zorn, 2004, Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation, J Exp Med, 199, 1133, 10.1084/jem.20031560 Baroni, 2006, Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis, N Engl J Med, 354, 2667, 10.1056/NEJMoa052955 Svegliati, 2007, Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease, Blood, 110, 237, 10.1182/blood-2007-01-071043 Bruggen, 2013, Diverse T cell responses characterize the different manifestations of cutaneous graft-versus-host disease, Blood, 123, 290, 10.1182/blood-2013-07-514372 Broady, 2010, Cutaneous GVHD is associated with the expansion of tissue localized Th1 and not Th17 cells, Blood, 116, 5748, 10.1182/blood-2010-07-295436 Zorn, 2005, Reduced frequency of FOXP31 CD41CD251 regulatory T cells in patients with chronic graft-versus-host disease, Blood, 106, 2903, 10.1182/blood-2005-03-1257 Matsuoka, 2010, Altered regulatory T cell homeostasis in patients with CD41 lymphopenia following allogeneic hematopoietic stem cell transplantation, J Clin Invest, 120, 1479, 10.1172/JCI41072 Sproat, 2011, Vitamin D level after allogeneic hematopoietic stem cell transplant, Biol Blood Marrow Transplant, 17, 1079, 10.1016/j.bbmt.2010.12.704 Perera, 2015, The relationship between pre-transplant 25-hydroxyvitamin D levels, survival and graft-versus-host disease, in allogeneic haematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 21, S266, 10.1016/j.bbmt.2014.11.482 Glotzbecker, 2013, Low levels of 25-hydroxyvitamin D before allogeneic hematopoietic SCT correlate with the development of chronic GVHD, Bone Marrow Transplant, 48, 593, 10.1038/bmt.2012.177 Silva, 2011, Effect of vitamin D treatment in chronic GVHD, Bone Marrow Transplant, 46, 1395, 10.1038/bmt.2010.317 Rosenblatt, 2010, Immunomodulatory effects of vitamin D: implications for GVHD, Bone Marrow Transplant, 45, 1463, 10.1038/bmt.2009.366 Ganetsky, 2014, Vitamin D deficiency predicts acute cutaneous graft versus host disease in reduced intensity allogeneic hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 20, S257, 10.1016/j.bbmt.2013.12.451 von Bahr, 2015, Increased incidence of chronic GVHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation, Bone Marrow Transplant, 50, 1217, 10.1038/bmt.2015.123 Cavalier, 2006, Skin cancer after nonmyeloablative hematopoetic stem cell transplantation, Bone Marrow Transplant, 37, 1103, 10.1038/sj.bmt.1705362 Holick, 2011, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice guideline, J Clin Endocrinol Metab, 96, 1911, 10.1210/jc.2011-0385